ES2144857T3 - Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso. - Google Patents

Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.

Info

Publication number
ES2144857T3
ES2144857T3 ES97919465T ES97919465T ES2144857T3 ES 2144857 T3 ES2144857 T3 ES 2144857T3 ES 97919465 T ES97919465 T ES 97919465T ES 97919465 T ES97919465 T ES 97919465T ES 2144857 T3 ES2144857 T3 ES 2144857T3
Authority
ES
Spain
Prior art keywords
manufacture
diseases
treatment
nervous system
benzonaphthalenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97919465T
Other languages
English (en)
Inventor
Xavier Vige
Jesus Benavides
Braham Shroot
Veronique Taupin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Application granted granted Critical
Publication of ES2144857T3 publication Critical patent/ES2144857T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UTILIZACION DE COMPUESTOS DE FORMULA GENERAL (I) PARA LA FABRICACION DE MEDICAMENTOS UTILES EN EL TRATAMIENTO DE LAS NEUROPATIAS PERIFERICAS, DE LAS ENFERMEDADES NEURODEGENERATIVAS CENTRALES Y DE LAS ENFERMEDADES AUTOINMUNES DEL SISTEMA NERVIOSO.
ES97919465T 1996-04-05 1997-04-02 Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso. Expired - Lifetime ES2144857T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9604359A FR2747041B1 (fr) 1996-04-05 1996-04-05 Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des neuropathies

Publications (1)

Publication Number Publication Date
ES2144857T3 true ES2144857T3 (es) 2000-06-16

Family

ID=9490993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97919465T Expired - Lifetime ES2144857T3 (es) 1996-04-05 1997-04-02 Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.

Country Status (23)

Country Link
US (1) US6043280A (es)
EP (1) EP0900078B1 (es)
JP (1) JP2000512619A (es)
KR (1) KR20000005179A (es)
CN (1) CN1221341A (es)
AT (1) ATE189385T1 (es)
AU (1) AU717704B2 (es)
BR (1) BR9708511A (es)
CA (1) CA2250755A1 (es)
CZ (1) CZ317698A3 (es)
DE (1) DE69701258T2 (es)
ES (1) ES2144857T3 (es)
FR (1) FR2747041B1 (es)
GR (1) GR3033061T3 (es)
HU (1) HUP9902167A3 (es)
NO (1) NO984651L (es)
NZ (1) NZ332158A (es)
PL (1) PL329219A1 (es)
PT (1) PT900078E (es)
RU (1) RU2160098C2 (es)
SK (1) SK133398A3 (es)
WO (1) WO1997037648A1 (es)
ZA (1) ZA972875B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of emphysema using rar selective retinoid antagonists
WO2001034633A2 (en) * 1999-11-12 2001-05-17 Fred Hutchinson Cancer Research Center Methods for treatment of human huntington's disease and methods of screening for active agents
TWI306450B (en) * 2001-12-13 2009-02-21 Wyeth Corp Substituted phenyl naphthalenes as estrogenic agents
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
AU2004226430A1 (en) * 2003-03-28 2004-10-14 Acadia Pharmaceuticals Inc. Muscarinic M1 receptor agonists for pain management
EP4066826B1 (en) 2010-09-01 2024-03-06 Thomas Jefferson University Retinoic acid receptor gamma agonists for muscle repair and regeneration
KR101981930B1 (ko) 2017-08-10 2019-05-27 주식회사 에니텍시스 랜딩 장치

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US5455248A (en) * 1993-09-14 1995-10-03 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts, and compositions and method of use thereof
RU2056852C1 (ru) * 1994-03-18 1996-03-27 Иван Николаевич Головистиков Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний

Also Published As

Publication number Publication date
CN1221341A (zh) 1999-06-30
HUP9902167A3 (en) 2000-07-28
AU717704B2 (en) 2000-03-30
PT900078E (pt) 2000-07-31
CZ317698A3 (cs) 1999-02-17
GR3033061T3 (en) 2000-08-31
JP2000512619A (ja) 2000-09-26
ATE189385T1 (de) 2000-02-15
ZA972875B (en) 1997-10-31
BR9708511A (pt) 1999-08-03
CA2250755A1 (fr) 1997-10-16
FR2747041A1 (fr) 1997-10-10
RU2160098C2 (ru) 2000-12-10
SK133398A3 (en) 1999-12-10
WO1997037648A1 (fr) 1997-10-16
US6043280A (en) 2000-03-28
NZ332158A (en) 2000-06-23
EP0900078B1 (fr) 2000-02-02
NO984651D0 (no) 1998-10-05
HUP9902167A2 (hu) 2000-04-28
FR2747041B1 (fr) 1998-05-22
EP0900078A1 (fr) 1999-03-10
DE69701258T2 (de) 2000-12-21
AU2392797A (en) 1997-10-29
DE69701258D1 (de) 2000-03-09
PL329219A1 (en) 1999-03-15
NO984651L (no) 1998-12-03
KR20000005179A (ko) 2000-01-25

Similar Documents

Publication Publication Date Title
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
ES2086623T3 (es) Azaheterociclilmetil-cromanos como principios activos para el tratamiento de enfermedades del sistema nervioso central.
ES2191192T3 (es) Tienopirimidinas.
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
ES2188793T3 (es) Agente para el tratamiento de las enfermedades neurodegenerativas.
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
SV1995000007A (es) Derivados del acido micofenolico 5-substituidos.
MX9301634A (es) Quinuclidinas peptidicas.
ES2096312T3 (es) Derivado de quinuclidina como antagonista de la sustancia p.
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
YU1097A (sh) 2-okso i 2-tio-1,2-dihidrohinolinil-oksazolidinoni
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
ES2184106T3 (es) Utilizacion del derivado de k-252a en el tratamiento de trastornos del sistema nervioso periferico o central, y de la hiperproduccion de citoquinas.
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
AR028705A1 (es) Bis-arilsulfonas
TR200200716T2 (tr) Ketiyapin granülleri
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
IL163951A0 (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
AR002272A1 (es) Uso de amidas de fenilciclohexilcarboxilicos
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ES2095984T3 (es) 2,3-dihidropirano(2,3-b)piridinas aminometil sustituidas, procedimiento para su preparacion y su uso en medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 900078

Country of ref document: ES